Compare BIO-TECHNE Corp (TECH) vs Vanguard High Dividend Yield ETF (VYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Vanguard High Dividend Yield ETF — how do they compare? BIO-TECHNE Corp trades at $72.44 (market cap $11.36B), while Vanguard High Dividend Yield ETF trades at $158.9 (market cap $100.80B). The key difference: Vanguard High Dividend Yield ETF is far larger — about 8.9× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Vanguard High Dividend Yield ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 64 Days and Vanguard High Dividend Yield ETF for 139 Days on average.
| TECH | VYM | |
|---|---|---|
Market Cap | $11.36B | $100.80B |
Volume | 5,390,331 | 908,176 |
Sector | Health | — |
52-Week High | $72.61 | $167.03 |
52-Week Low | $43.31 | $137.47 |
Typical Hold Time | 64 Days | 139 Days |
Enterprise Value | $11.39B | — |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.46, near its 52-week high of $72.70, with a slight daily decline of 0.1%. The stock shows a bullish technical signal from moving averages, while oscillators are neutral. Recent earnings have been mixed, with a Q2 2026 beat but a Q1 miss. The company maintains strong gross margins of 65.77%, though net income margin has compressed to 14.97% in 2025 from 24.6% in 2022. A significant development is the shareholder-approved acquisition by Merck KGaA at $73.00 per share, pending completion.
The pending acquisition at $73.00 offers a clear near-term upside of about 0.7% from the current price, limiting downside risk. However, execution risks remain until deal closure, and profitability pressures pose concerns for standalone operations. Analyst consensus is divided with 46% Buy and 54% Hold ratings, reflecting cautious optimism amid transition uncertainty.
VYM trades at $158.75, up 0.83% with a bearish technical signal from moving averages. The ETF maintains consistent dividend payments, with a recent $0.89 dividend declared for September 2026. Technical indicators show mixed signals with neutral oscillators and key support at $156. Recent media coverage highlights VYM's role in income strategies but notes competitive pressure from alternative dividend ETFs offering higher yields and performance.
VYM faces headwinds from underperformance relative to peers like SCHD and IDV, with concerns about dividend sustainability in its holdings. The ETF's broad diversification provides stability but limits upside potential. Key risks include sector concentration in dividend-cut vulnerable stocks and competitive yield pressures. Analyst sentiment remains neutral given its steady but modest income profile.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Vanguard High Dividend Yield ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →
